Transport of L-carnitine in human corneal and conjunctival epithelial cells

Molecular Vision

Volumn 16, Issue , 2010, Pages 1823-1831

  Xu, Shunjiang ^a   Flanagan, Judith L ^a   Simmons, Peter A ^b   Vehige, Joseph ^b   Willcox, Mark D ^a   Garrett, Qian ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ALLERGAN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOBICYCLO[2.2.1]HEPTANE 2 CARBOXYLIC ACID; 2,4 DINITROPHENOL; CARNITINE; GAMMA BUTYROBETAINE; IODOACETIC ACID; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; SODIUM AZIDE; TETRYLAMMONIUM;

ARTICLE; BINDING AFFINITY; CELL CULTURE; CELL ENERGY; CONCENTRATION RESPONSE; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CORNEA EPITHELIUM; DRUG PROTEIN BINDING; DRUG TRANSPORT; DRUG UPTAKE; EPITHELIUM CELL; HUMAN; HUMAN CELL; PH; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SODIUM CELL LEVEL;

AMINO ACID TRANSPORT SYSTEMS; ANTIBODIES; BIOLOGICAL TRANSPORT; CARNITINE; CATIONS; CELL LINE; CONJUNCTIVA; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; NORBORNANES; ORGANIC CATION TRANSPORT PROTEINS; RNA, MESSENGER; SODIUM; TEMPERATURE; TIME FACTORS;

EID: 77956958965     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Pessotto P, Liberati R, Petrella O, Romanelli L, Calvani M, Peluso G. In experimental diabetes the decrease in the eye of lens carnitine levels is an early important and selective event. Exp Eye Res 1997; 64: 195-201.
2. Corrales RM, Luo L, Chang EY, Pflugfelder SC. Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells. Cornea 2008; 27: 574-579.
3. Garrett Q, Min-Hsuan Shih S, Simmons PA, Vehige J, Willcox M. Carnitine and the Potential Osmoprotectants Protect Corneal Epithelial Cells from Hyperosmolar Solution Induced Damage. ARVO Annual Meeting; 2010 May 2-6; Fort Lauderdale (FL).
4. Simmons P, Chang-Lin J, Chung Q, Vehige J, Carlisle-Wilcox C, Welty D. Selection of compatible solutes for inclusion in a lubricant eye drop. TFOS meeting 2007 September, 2007; Sicily, Italy.
5. Kerner J, Hoppel C. Genetic disorders of carnitine metabolism and their nutritional management. Annu Rev Nutr 1998; 18: 179-206.
6. Kerner J, Hoppel C. Fatty acid import into mitochondria. Biochim Biophys Acta 2000; 1486: 1-17.
7. Pescosolido N, Imperatrice B, Koverech A, Messano M. Lcarnitine and short chain ester in tears from patients with dry eye. Optom Vis Sci 2009; 86: E132-E138.
8. Simmons P, Chang-Lin J, Chung Q, Vehige J, Welty D. Effect of compatible solutes on transepithelial electrical resistance and uptake in primary rabbit corneal epithelial cell layers model. ARVO Annual Meeting; 2007 May 6-10; Fort Lauderdale (FL).
9. Ueda H, Horibe Y, Kim KJ, Lee VH. Functional characterization of organic cation drug transport in the pigmented rabbit conjunctiva. Invest Ophthalmol Vis Sci 2000; 41: 870-876.
10. Garrett Q, Xu S, Simmons PA, Vehige J, Flanagan JL, Willcox MD. Expression and localization of carnitine/organic cation transporter OCTN1 and OCTN2 in ocular epithelium. Invest Ophthalmol Vis Sci 2008; 49: 4844-4849.
11. Kwok B, Yamauchi A, Rajesan R, Chan L, Dhillon U, Gao W, Xu H, Wang B, Takahashi S, Semple J, Tamai I, Nezu J, Tsuji A, Harper P, Ito S. Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A. Am J Physiol Regul Integr Comp Physiol 2006; 290: R793-R802.
12. Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Arch 2004; 447: 666-676.
13. Grube M, Meyerzu Schwabedissen HE, Prager D, Haney J, Moritz KU, Meissner K, Rosskopf D, Eckel L, Bohm M, Jedlitschky G, Kroemer HK. Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5). Circulation 2006; 113: 1114-1122.
14. Grube M, Schwabedissen HM, Draber K, Prager D, Moritz KU, Linnemann K, Fusch C, Jedlitschky G, Kroemer HK. Expression, localization, and function of the carnitine transporter OCTN2 (slc22a5) in human placenta. Drug Metab Dispos 2005; 33: 31-37.
15. Lahjouji K, Elimrani I, Lafond J, Leduc L, Qureshi IA, Mitchell GA. L-Carnitine transport in human placental brush-border membranes is mediated by the sodium-dependent organic cation transporter OCTN2. Am J Physiol Cell Physiol 2004; 287: C263-C269.
16. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, Tsuji A. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 1999; 289: 768-773.
17. Tamai I, Ohashi R, Nezu JI, Sai Y, Kobayashi D, Oku A, Shimane M, Tsuji A. Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 2000; 275: 40064-40072.
18. Tamai I, Yabuuchi H, Nezu J, Sai Y, Oku A, Shimane M, Tsuji A. Cloning and characterization of a novel human pHdependent organic cation transporter, OCTN1. FEBS Lett 1997; 419: 107-111.
19. Horvath G, Schmid N, Fragoso MA, Schmid A, Conner GE, Salathe M, Wanner A. Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am J Respir Cell Mol Biol 2007; 36: 53-60.
20. Tamai I, Ohashi R, Nezu J, Yabuuchi H, Oku A, Shimane M, Sai Y, Tsuji A. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J Biol Chem 1998; 273: 20378-20382.
21. Enomoto A, Wempe MF, Tsuchida H, Shin HJ, Cha SH, Anzai N, Goto A, Sakamoto A, Niwa T, Kanai Y, Anders MW, Endou H. Molecular identification of a novel carnitine transporter specific to human testis. Insights into the mechanism of carnitine recognition. J Biol Chem 2002; 277: 36262-36271.
22. Nakanishi T, Hatanaka T, Huang W, Prasad PD, Leibach FH, Ganapathy ME, Ganapathy V. Na+- and Cl-coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol 2001; 532: 297-304.
23. Garrett Q, Simmons PA, Xu S, Vehige J, Zhao Z, Ehrmann K, Willcox M. Carboxymethylcellulose binds to human corneal epithelial cells and is a modulator of corneal epithelial wound healing. Invest Ophthalmol Vis Sci 2007; 48: 1559-1567.
24. Gipson IK, Spurr-Michaud S, Argueso P, Tisdale A, Ng TF, Russo CL. Mucin gene expression in immortalized human corneal-limbal and conjunctival epithelial cell lines. Invest Ophthalmol Vis Sci 2003; 44: 2496-2506.
25. Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A. Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2. Mol Pharmacol 2001; 59: 358-366.
26. Yokogawa K, Miya K, Tamai I, Higashi Y, Nomura M, Miyamoto K, Tsuji A. Characteristics of L-carnitine transport in cultured human hepatoma HLF cells. J Pharm Pharmacol 1999; 51: 935-940.
27. Tachikawa M, Takeda Y, Tomi M, Hosoya K. Involvement of OCTN2 in the transport of acetyl-L-carnitine across the inner blood-retinal barrier. Invest Ophthalmol Vis Sci 2010; 51: 430-436.
28. Stieger B, O'Neill B, Krahenbuhl S. Characterization of Lcarnitine transport by rat kidney brush-border-membrane vesicles. Biochem J 1995; 309: 643-647.
29. Okamura N, Ohnishi S, Shimaoka H, Norikura R, Hasegawa H. Involvement of recognition and interaction of carnitine transporter in the decrease of L-carnitine concentration induced by pivalic acid and valproic acid. Pharm Res 2006; 23: 1729-1735.
30. Ohnishi S, Okamura N, Sakamoto S, Hasegawa H, Norikura R, Kanaoka E, Takahashi K, Horie K, Sakamoto K, Baba T. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment. Drug Metab Pharmacokinet 2008; 23: 293-303.
31. Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A. Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ther 1999; 291: 778-784.
32. Wu X, Huang W, Prasad PD, Seth P, Rajan DP, Leibach FH, Chen J, Conway SJ, Ganapathy V. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther 1999; 290: 1482-1492.
33. Tachikawa M, Takeda Y, Tomi M, Hosoya K. Involvement of OCTN2 in the Transport of Acetyl-L-Carnitine across the Inner Blood-Retinal Barrier. Invest Ophthalmol Vis Sci 2010; 51: 430-436.
34. D'Argenio G, Calvani M, Casamassimi A, Petillo O, Margarucci S, Rienzo M, Peluso I, Calvani R, Ciccodicola A, Caporaso N, Peluso G. Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes. FASEB J 2006; 20: 2544-2546.
35. Wu X, George RL, Huang W, Wang H, Conway SJ, Leibach FH, Ganapathy V. Structural and functional characteristics and tissue distribution pattern of rat OCTN1, an organic cation transporter, cloned from placenta. Biochim Biophys Acta 2000; 1466: 315-327.